News Breaks |
|
|
| March 15, 2013 |
| 08:58 EDT |  | ANAC | Anacor Pharmaceuticals looks inexpensive, says Cowen
Cowen believes Anacor Pharmaceuticals looks inexpensive relative to its commercial opportunity for its its candidates. The firm cited potential for tavaborole's price and revenue potential after a competitor raised its prices as well as its candidate for atopic dermatitis which is expected to enter Phase III trials later this year. Shares are Outperform rated. |
|
|
News For ANAC From The Last 14 Days Check below for free stories on ANAC the last two weeks. |
|
|
| There are no results for ANAC |
|
|
|
|
